252 related articles for article (PubMed ID: 33159376)
21. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
Kim CG; Ahn JB; Jung M; Beom SH; Kim C; Kim JH; Heo SJ; Park HS; Kim JH; Kim NK; Min BS; Kim H; Koom WS; Shin SJ
Br J Cancer; 2016 Jun; 115(1):25-33. PubMed ID: 27228287
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.
Del Campo AB; Carretero J; Muñoz JA; Zinchenko S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F; Aptsiauri N
Cancer Gene Ther; 2014 Aug; 21(8):317-32. PubMed ID: 24971583
[TBL] [Abstract][Full Text] [Related]
23. The Association Between Mutations in BRAF and Colorectal Cancer-Specific Survival Depends on Microsatellite Status and Tumor Stage.
Bläker H; Alwers E; Arnold A; Herpel E; Tagscherer KE; Roth W; Jansen L; Walter V; Kloor M; Chang-Claude J; Brenner H; Hoffmeister M
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):455-462.e6. PubMed ID: 29660527
[TBL] [Abstract][Full Text] [Related]
24. Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma.
Wright CM; Dent OF; Newland RC; Barker M; Chapuis PH; Bokey EL; Young JP; Leggett BA; Jass JR; Macdonald GA
Gut; 2005 Jan; 54(1):103-8. PubMed ID: 15591513
[TBL] [Abstract][Full Text] [Related]
25. Relationship Between ABO Blood Group and Microsatellite Instability in Colorectal Cancer: A Retrospective Single-Center Study.
Karaoglan BB; Akyol C; Unal AE; Kuzu A; Savaş B; Utkan G
J Gastrointest Cancer; 2024 Mar; 55(1):281-286. PubMed ID: 37414939
[TBL] [Abstract][Full Text] [Related]
26. Low-Level Microsatellite Instability as a Potential Prognostic Factor in Sporadic Colorectal Cancer.
Lee SY; Kim DW; Lee HS; Ihn MH; Oh HK; Min BS; Kim WR; Huh JW; Yun JA; Lee KY; Kim NK; Lee WY; Kim HC; Kang SB
Medicine (Baltimore); 2015 Dec; 94(50):e2260. PubMed ID: 26683947
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomas.
Katkoori VR; Shanmugam C; Jia X; Vitta SP; Sthanam M; Callens T; Messiaen L; Chen D; Zhang B; Bumpers HL; Samuel T; Manne U
PLoS One; 2012; 7(1):e30020. PubMed ID: 22276141
[TBL] [Abstract][Full Text] [Related]
28. Molecular profile and copy number analysis of sporadic colorectal cancer in Taiwan.
Lin CH; Lin JK; Chang SC; Chang YH; Chang HM; Liu JH; Li LH; Chen YT; Tsai SF; Chen WS
J Biomed Sci; 2011 Jun; 18(1):36. PubMed ID: 21645411
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and predictive significance of microsatellite instability in stage II colorectal carcinoma: An 8-year study from a tertiary center in South India.
Paulose RR; Ail DA; Biradar S; Vasudevan A; Sundaram KR
Indian J Cancer; 2019; 56(4):302-308. PubMed ID: 31607697
[TBL] [Abstract][Full Text] [Related]
30. The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma.
Paschen A; Arens N; Sucker A; Greulich-Bode KM; Fonsatti E; Gloghini A; Striegel S; Schwinn N; Carbone A; Hildenbrand R; Cerwenka A; Maio M; Schadendorf D
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3297-305. PubMed ID: 16740750
[TBL] [Abstract][Full Text] [Related]
31. Relationship between genetic alterations and prognosis in sporadic colorectal cancer.
Chang SC; Lin JK; Yang SH; Wang HS; Li AF; Chi CW
Int J Cancer; 2006 Apr; 118(7):1721-7. PubMed ID: 16231316
[TBL] [Abstract][Full Text] [Related]
32. HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers.
Walsh MD; Dent OF; Young JP; Wright CM; Barker MA; Leggett BA; Bokey L; Chapuis PH; Jass JR; Macdonald GA
Int J Cancer; 2009 Sep; 125(5):1231-7. PubMed ID: 19462453
[TBL] [Abstract][Full Text] [Related]
33. Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters.
Pakish JB; Zhang Q; Chen Z; Liang H; Chisholm GB; Yuan Y; Mok SC; Broaddus RR; Lu KH; Yates MS
Clin Cancer Res; 2017 Aug; 23(15):4473-4481. PubMed ID: 28264871
[No Abstract] [Full Text] [Related]
34. Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assay.
Esemuede I; Forslund A; Khan SA; Qin LX; Gimbel MI; Nash GM; Zeng Z; Rosenberg S; Shia J; Barany F; Paty PB
Ann Surg Oncol; 2010 Dec; 17(12):3370-8. PubMed ID: 20703819
[TBL] [Abstract][Full Text] [Related]
35. MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.
Torshizi Esfahani A; Seyedna SY; Nazemalhosseini Mojarad E; Majd A; Asadzadeh Aghdaei H
J Cell Physiol; 2019 Aug; 234(8):13128-13136. PubMed ID: 30549036
[TBL] [Abstract][Full Text] [Related]
36. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
[TBL] [Abstract][Full Text] [Related]
37. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers.
de Miranda NF; Nielsen M; Pereira D; van Puijenbroek M; Vasen HF; Hes FJ; van Wezel T; Morreau H
J Pathol; 2009 Sep; 219(1):69-76. PubMed ID: 19462419
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
[TBL] [Abstract][Full Text] [Related]
39. Microsatellite instability test using peptide nucleic acid probe-mediated melting point analysis: a comparison study.
Jang M; Kwon Y; Kim H; Kim H; Min BS; Park Y; Kim TI; Hong SP; Kim WK
BMC Cancer; 2018 Dec; 18(1):1218. PubMed ID: 30514259
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial.
Tikidzhieva A; Benner A; Michel S; Formentini A; Link KH; Dippold W; von Knebel Doeberitz M; Kornmann M; Kloor M
Br J Cancer; 2012 Mar; 106(6):1239-45. PubMed ID: 22353804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]